doi:10.1111/j.1471-0528.1968.tb02022.x
Nasal sprays and sublingual drops exist but lack robust human data
Derived from the larger protein thymosin beta-4, TB-500 consists of a smaller amino acid fragment
16231630, Nov
These data also suggest that the effect of BPC-157 on alkali-burn wound repair is, apparently, comparable with that of bFGF
Standard AOD-9604 Dosing Protocol Subcutaneous Injection Dosing: Beginner: 250 mcg per dose, once daily Intermediate: 300-400 mcg per dose, once daily or divided into two doses Advanced: 500 mcg per dose, once daily or 250 mcg twice daily Oral Administration Dosing (if using oral formulation): Standard: 1-2 mg per dose, once daily on empty stomach Higher protocols: Up to 5-10 mg daily, as studied in clinical trials Frequency: Once daily (morning preferred) or twice daily (morning and early afternoon) Timing: Best administered on an empty stomach, typically upon waking or before exercise Cycle Length: 12-16 weeks for initial assessment, with potential for longer protocols based on response Off Cycle: 4-8 weeks between cycles, though not strictly required based on current research Note: Start at the lower end of the dosing range to assess individual tolerance